Single dose oral etoricoxib for acute postoperative pain in adults
- PMID: 24809657
- PMCID: PMC6485336
- DOI: 10.1002/14651858.CD004309.pub4
Single dose oral etoricoxib for acute postoperative pain in adults
Abstract
Background: This is an updated version of the original Cochrane review first published in Issue 2, 2009, and updated in Issue 4, 2012.Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor licensed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain in some jurisdictions. This class of drugs is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs).
Objectives: To assess the efficacy and adverse effects of single dose etoricoxib for acute postoperative pain using methods that permit accurate comparison with other analgesics evaluated in the same way, using criteria of efficacy recommended by in-depth studies at the individual patient level.
Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the Oxford Pain Database, www.clinicaltrials.gov, and reference lists of articles. The date of the most recent search was 31 January 2014.
Selection criteria: Randomised, double-blind, placebo-controlled clinical trials of single dose, oral etoricoxib for acute postoperative pain in adults.
Data collection and analysis: Two review authors independently considered studies for inclusion in the review, assessed quality, and extracted data. We used the area under the pain relief versus time curve to derive the proportion of participants prescribed etoricoxib or placebo with at least 50% pain relief over six hours, using validated equations. We calculated relative risk (RR) and number needed to treat to benefit (NNT). We used information on use of rescue medication to calculate the proportion of participants requiring rescue medication and the weighted mean of the median time to use. We also collected information on adverse events.
Main results: We identified no new studies for this updated review, which includes six studies with 1214 participants in comparisons of etoricoxib with placebo. All six studies reported on the 120 mg dose (798 participants in a comparison with placebo). Sixty-six per cent of participants with etoricoxib 120 mg and 12% with placebo reported at least 50% pain relief (NNT 1.8 (1.7 to 2.0); high-quality evidence). For dental studies only, the NNT was 1.6 (1.5 to 1.8). A single dose of 90 mg produced similar results in one large trial. Other doses (60, 180, and 240 mg) were each studied in only one treatment arm.Significantly fewer participants used rescue medication over 24 hours when taking etoricoxib 120 mg than placebo (NNT to prevent remedication 2.2 (1.9 to 2.8)), and the median time to use of rescue medication was 20 hours for etoricoxib and two hours for placebo. Adverse events were reported at a similar rate to placebo (moderate-quality evidence), with no serious events.
Authors' conclusions: Single-dose oral etoricoxib produces high levels of good quality pain relief after surgery, and adverse events did not differ from placebo in these studies. The 120 mg dose is as effective as, or better than, other commonly used analgesics.
Conflict of interest statement
SD and RAM have received research support from charities, government and industry at various times, but none related to this review. RAM has consulted for, and received lecture fees from, various pharmaceutical companies related to analgesics and other healthcare interventions in the last five years. None relate to this review.
Figures













Update of
-
Single dose oral etoricoxib for acute postoperative pain in adults.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004309. doi: 10.1002/14651858.CD004309.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 May 08;(5):CD004309. doi: 10.1002/14651858.CD004309.pub4. PMID: 22513922 Updated.
References
References to studies included in this review
Chang 2004 {published data only}
-
- Chang DJ, Desjardins PJ, King TR, Erb T, Geba GP. The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: a randomized, double‐blind clinical trial. Anesthesia and Analgesia 2004;99(3):807‐15. [DOI: 10.1213/01.ANE.0000133141.75831.57] - DOI - PubMed
Daniels 2011 {published data only}
Malmstrom 2004a {published data only}
-
- Malmstrom K, Sapre A, Couglin H, Agrawal NG, Mazenko RS, Fricke JR Jr. Etoricoxib in acute pain associated with dental surgery: a randomized, double‐blind, placebo‐ and active comparator‐controlled dose‐ranging study. Clinical Therapeutics 2004;26(5):667‐79. [DOI: 10.1016/S0149-2918(04)90067-7] - DOI - PubMed
Malmstrom 2004b {published data only}
-
- Malmstrom K, Kotey P, Coughlin H, Desjardins PJ. A randomized, double‐blind, parallel‐group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. Clinical Journal of Pain 2004;20(3):147‐55. - PubMed
Malmstrom 2005 {published data only}
-
- Malmstrom K, Ang J, Fricke JR, Shingo S, Reicin A. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single‐dose study in acute dental impaction pain. Current Medical Research and Opinion 2005;21(1):141‐9. [DOI: 10.1185/030079904X17983] - DOI - PubMed
Rasmussen 2005 {published data only}
-
- Rasmussen GL, Malmstrom K, Bourne MH, Jove M, Rhondeau SM, Kotey P. Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia 2005;101(4):1104‐11. [DOI: 10.1213/01.ane.0000169294.41210.9e] - DOI - PubMed
References to studies excluded from this review
Anonymous 2001 {published data only}
-
- Anonymous. Investigational COX‐2 inhibitor relieves pain in a dental model. Current Pain and Headache Reports 2001;11(8):1059‐62. - PubMed
Chalini 2005 {published data only}
-
- Chalini S, Raman U. Comparative efficacy of aceclofenac and etoricoxib in post extraction pain control: randomized control trial. Indian Journal of Dental Research 2005;16(2):47‐50. - PubMed
Viscusi 2012 {published and unpublished data}
-
- A double‐blind, placebo‐controlled, multicenter trial to study the efficacy and tolerability of MK0663/Etoricoxib in the treatment of pain after abdominal hysterectomy. www.ClinicalTrials.gov (accessed 31 January 2014). [ClinicalTrials.gov ID: NCT00788710]
-
- Viscusi ER, Frenkl TL, Hartrick CT, Rawal N, Kehlet H, Papanicolaou D, et al. A double‐blind, placebo‐controlled, multicenter trial to study the efficacy and tolerability of MK0663/Etoricoxib in the treatment of pain after abdominal hysterectomy. Current Medical Research and Opiniion 2012;28(8):1323‐5. [DOI: 10.1185/03007995.2012.707121] - DOI - PubMed
Additional references
Barden 2004a
-
- Barden J, Edwards JE, McQuay HJ, Wiffen PJ, Moore RA. Relative efficacy of oral analgesics after third molar extraction. British Dental Journal 2004;197(7):407‐11. - PubMed
Barden 2004b
Barden 2004c
Collins 1997
-
- Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72:95‐7. - PubMed
Collins 2001
-
- Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ. Seeking a simple measure of analgesia for mega‐trials: is a single global assessment good enough?. Pain 2001;91:189‐94. - PubMed
Cook 1995
Cooper 1991
-
- Cooper SA. Single‐dose analgesic studies: the upside and downside of assay sensitivity. In: Max MB, Portenoy RK, Laska EM editor(s). The Design of Analgesic Clinical Trials. Advances in Pain Research and Therapy. Vol. 18, New York: Raven Press, 1991:117‐24.
Derry 2009a
Derry 2009b
Derry 2009c
Derry 2011
Derry 2013
Edwards 1999
Garner 2002
Grahame‐Smith 2002
-
- Grahame‐Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd Edition. Oxford: Oxford University Press, 2002.
Hawkey 1999
-
- Hawkey CJ. COX‐2 inhibitors. Lancet 1999;353(9149):307‐14. - PubMed
Hawkey 2001
-
- Hawkey CJ, Jones JI. Gastrointestinal safety of COX‐2 specific inhibitors. Gastroenterology Clinics of North America 2001;30(4):921‐36. - PubMed
Jadad 1996a
Jadad 1996b
L'Abbé 1987
-
- L'Abbé KA, Detsky AS, O'Rourke K. Meta‐analysis in clinical research. Annals of Internal Medicine 1987;107:224‐33. - PubMed
McQuay 2005
Moher 1999
Moore 1996
-
- Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66(2‐3):229‐37. - PubMed
Moore 1997a
-
- Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data. Pain 1997;69(1‐2):127‐30. - PubMed
Moore 1997b
-
- Moore A, Moore O, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain 1997;69(3):311‐5. - PubMed
Moore 1998
Moore 2003
-
- Moore RA, Edwards JE, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0‐19‐263247‐7]
Moore 2005a
Moore 2005b
-
- Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta‐analysis of information from company clinical trial reports. Arthritis Research & Therapy 2005;7(3):R644‐65. [DOI: 10.1186/ar1704] - DOI - PMC - PubMed
Moore 2006
-
- Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0‐19‐856604‐2]
Moore 2008
-
- Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978‐0‐931092‐69‐5]
Moore 2011a
Moore 2011b
-
- Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta‐analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982‐9. [DOI: ] - PubMed
Morris 1995
PACT 2013
-
- Prescription Cost Analysis, England 2012. NHS Health and Social Care Information Centre 2013. [ISBN: 978‐1‐84‐636859‐2]
Patrono 2009
-
- Patrono C, Baigent C. Low‐dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. Molecular Interventions 2009;9(1):31‐9. - PubMed
RevMan 2011 [Computer program]
-
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Roy 2010
Ruff 2011
-
- Ruff CT, Morrow DA, Jarolim P, Ren F, Contant CF, Kaur A, et al. Evaluation of NT‐proBNP and high sensitivity C‐reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. Journal of Rheumatology 2011;38(6):1071‐8. [DOI: 10.3899/jrheum.100880] - DOI - PubMed
Straube 2005
Toms 2008
References to other published versions of this review
Clarke 2009
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials